✦ LIBER ✦

Pharmacological activity of DTPA linked to protein-based drug carrier systems

✍ Scribed by Martin Michaelis; Klaus Langer; Sonja Arnold; Hans-Wilhelm Doerr; Jörg Kreuter; Jindrich Cinatl Jr.

Book ID: 116289146
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 454 KB
Volume: 323
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2004.08.223

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implications of formulation design on li

Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain

✍ Salunkhe, Sachin S.; Bhatia, Neela M.; Bhatia, Manish S. 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 353 KB

A Novel Assay to Determine the Hemolytic

A Novel Assay to Determine the Hemolytic Activity of Drugs Incorporated in Colloidal Carrier Systems

✍ Thomas K. Bock; Bernd W. Müller 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 462 KB

Interactions of liposomes and lipid-base

Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo

✍ Sean C Semple; Arcadio Chonn; Pieter R Cullis 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 531 KB

Lipases and Phospholipases in Drug Devel

Lipases and Phospholipases in Drug Development (From Biochemistry to Molecular Pharmacology) || Rational Design of a Liposomal Drug Delivery System Based on Biophysical Studies of Phospholipase A2 Activity on Model Lipid Membranes

✍ MÃ¼ller, GÃ¼nter; Petry, Stefan 📂 Article 📅 2005 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 273 KB 👁 1 views

Secretory phospholipase A 2 (sPLA 2 ) belongs to a family of small interfacially active enzymes that catalyze the hydrolysis of phospholipids, yielding lysolipids and fatty acids. sPLA 2 is found in snake and bee venom and also in inflammatory and cancerous tissue. It is mainly active on organized l

Enhanced pH-responsive carrier system ba

Enhanced pH-responsive carrier system based on alginate and chemically modified carboxymethyl chitosan for oral delivery of protein drugs: Preparation and in-vitro assessment

✍ Ibrahim M. El-Sherbiny 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 964 KB

Challenges to the development of bryosta

Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ

✍ Kazuhiro Irie; Ryo C. Yanagita; Yu Nakagawa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

## Abstract Protein kinase C (PKC) isozymes are widely recognized as targets for anticancer therapy, and recent investigations demonstrated that PKC activators are potential therapeutic candidates for Alzheimer's disease and acquired immune deficiency syndrome. However, concerns exist about their t